Author:
Schulman J. B.,Kashyap S.,Kim S. G.,Uludağ K.
Abstract
AbstractDynamic susceptibility contrast (DSC) MRI plays a pivotal role in the accurate diagnosis and prognosis of several neurovascular diseases, but is limited by its reliance on gadolinium, an intravascularly injected chelated metal. Here, we determined the feasibility of measuring perfusion using a DSC analysis of breath-hold-induced gradient-echo-MRI signal changes. We acquired data at both 3 T and 7 T from ten healthy participants who engaged in eight consecutive breath-holds. By pairing a novel arterial input function strategy with a standard DSC MRI analysis, we measured the cerebral blood volume, flow, and transit delay, and found values to agree with those documented in the literature using gadolinium. We also observed voxel-wise agreement between breath-hold and arterial spin labeling measures of cerebral blood flow. Breath-holding resulted in significantly higher contrast-to-noise (6.2 at 3 T vs. 8.5 at 7 T) and gray matter-to-white matter contrast at higher field strength. Finally, using a simulation framework to assess the effect of dynamic vasodilation on perfusion estimation, we found global perfusion underestimation of 20–40%. For the first time, we have assessed the feasibility of and limitations associated with using breath-holds for perfusion estimation with DSC. We hope that the methods and results presented in this study will help pave the way toward contrast-free perfusion imaging, in both basic and clinical research.
Funder
Institute for Basic Science
Canadian Institutes of Health Research
Publisher
Springer Science and Business Media LLC
Reference79 articles.
1. Copen, W. A., Schaefer, P. W. & Wu, O. MR perfusion imaging in acute ischemic stroke. Neuroimaging Clin. N. Am. 21, 259–283 (2011).
2. Harris, G. J. et al. Dynamic susceptibility contrast MR Imaging of regional cerebral blood volume in Alzheimer disease: A promising alternative to nuclear medicine. AJNR Am. J. Neuroradiol. 19(9), 1727–1732 (1998).
3. Law, M. et al. Gliomas: predicting time to progression or survival with cerebral blood volume measurements at dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. Radiology 247, 490–498 (2008).
4. Cohen, E. R. et al. Hypercapnic normalization of BOLD fMRI: comparison across field strengths and pulse sequences. Neuroimage 23, 613–624 (2004).
5. Jahng, G.-H., Li, K.-L., Ostergaard, L. & Calamante, F. Perfusion magnetic resonance imaging: A comprehensive update on principles and techniques. Korean J. Radiol. 15, 554–577 (2014).